Money
Briefing: Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says
Strategic angle: Eli Lilly's CEO expresses opposition to the White House's efforts to codify drug pricing reforms.
editorial-staff 10 days ago
3 articles tagged with "Eli Lilly"
Strategic angle: Eli Lilly's CEO expresses opposition to the White House's efforts to codify drug pricing reforms.
Strategic angle: Eli Lilly discusses the 'societal obligation' of GLP-1s amidst other biotech news.
Strategic angle: Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in a late-stage study.